Abstract:Abstract Disclosure: G. Pacheco Sanchez: None. M.L. Lopez: None. C. Jang: None. M.K. Evans: None. A.B. Zonderman: None. R. Kapadia: None. D.A. Nicholas: None. Health disparities (HD) disproportionately affect racial groups. One of the fastest growing HD worldwide with severe health consequences and high mortality rates is Type 2 Diabetes (T2D). T2D is an inflammatory disease associated with an increase in body mass index (BMI), a common obesity measurement, and clinically characterized by dysregulation of lipids or dyslipidemia. Reports suggest that compromised lipid metabolism can exacerbate chronic inflammation seen in T2D. Importantly, lipid metabolism can be impacted by systemic overabundance of lipids, a condition that has been reported to impact some racial groups, like African Americans (AA), in a disproportionate manner. Further, literature supports that elevated levels of inflammatory molecules correlate with excess of systemic lipids and impact the risk to develop T2D in AA women. Despite previous efforts, comprehensive biological information is still needed to determine the relationship of lipids and inflammation to the onset and/or progression of T2D. Here we show results from identified metabolic, and immunological features of serum and plasma samples derived from a cohort of AA and White individuals with and without T2D.Evaluation of clinical parameters related to metabolic state indicate that lipids measurements, such as blood concentrations of low-density cholesterol (LDL), high-density cholesterol (HDL), total cholesterol to HDL ratio, and triglycerides, are the main drivers of biological variability in our cohort, irrespective of diabetes status and race. Counterintuitively, Hemoglobin A1C and other glucose-related clinical standardized T2D measurements were not beneficial at addressing cohort variability. Based on results from our cytokine and chemokine analysis performed using a comprehensive 53-analytes Luminex panel we conclude that: : 1) Significant inflammatory molecules differences at a univariate level are seen when comparing AA and white in our total cohort, differences maintained irrespective of diabetes status; and 2) In a multivariate analysis, differential expression of a distinctive inflammatory cluster of cytokines and chemokines, composed of Eotaxin, IL6, IL18, IL27, IP10, MCP1, MDC and CXCL9, was identified between AA and whites, once again irrespective of diabetes status. Importantly, BMI had no major biological effect on any of the parameters we measured. Our results demonstrate a relation between lipids, not glucose, and the differential expression of inflammatory molecules, not conventionally reported for T2D, in a race-dependent manner. We anticipate this work to be the starting point for mechanistic studies addressing modulation of inflammatory responses by race-specific lipids profiles and components, for a better understanding of the immunometabolic contributors to HD. Presentation: Friday, June 16, 2023

LXR signaling pathways link cholesterol metabolism with risk for prediabetes and diabetes

Alterations of a Cellular Cholesterol Metabolism Network Are a Molecular Feature of Obesity-Related Type 2 Diabetes and Cardiovascular Disease

Aberrant activation of liver X receptors impairs pancreatic beta cell function through upregulation of sterol regulatory element-binding protein 1c in mouse islets and rodent cell lines

Circulating metabolite profile in young adulthood identifies long-term diabetes susceptibility: the Coronary Artery Risk Development in Young Adults (CARDIA) study

Regulation Of Insulin Resistance And Adiponectin Signaling In Adipose Tissue By Liver X Receptor Activation Highlights A Cross-Talk With Ppar Gamma

<strong><b></b></strong>Impaired Adipose Tissue Expansion Caused by LXR Activation is Associated with Insulin Resistance in HFD Mice

Abstract 12: Prospective Associations of Fatty Acids in the De Novo Lipogenesis Pathway and Stearoyl CoA-desaturase-1 Activity with Risk of Type 2 Diabetes: the Cardiovascular Health Study

Phenotypic and Genetic Characterization of Lower LDL Cholesterol and Increased Type 2 Diabetes Risk in the UK Biobank

An integrative multiomic network model links lipid metabolism to glucose regulation in coronary artery disease

Targeted Proteomics Reveals Functional Targets for Early Diabetes Susceptibility in Young Adults

LncRNA AC096664.3/PPAR‐γ/ABCG1‐dependent Signal Transduction Pathway Contributes to the Regulation of Cholesterol Homeostasis

Association between low-density lipoprotein cholesterol–lowering genetic variants and risk of type 2 diabetes: a meta-analysis

Newly identified loci that influence lipid concentrations and risk of coronary artery disease

High Glucose Aggravates Cholesterol Accumulation in Glomerular Endothelial Cells Through the LXRs/LncRNAOR13C9/ABCA1 Regulatory Network

A Lipid Signature with Perturbed Triacylglycerol Co-Regulation, Identified from Targeted Lipidomics, Predicts Risk for Type 2 Diabetes and Mediates the Risk from Adiposity in Two Prospective Cohorts of Chinese Adults.

Abstract 16605: Alterations of a Cellular Cholesterol Metabolism Network is a Molecular Feature of Obesity-Related Type 2 Diabetes and Cardiovascular Disease

Proteomic Predictors of Incident Diabetes: Results From the Atherosclerosis Risk in Communities (ARIC) Study

Abstract EP02: Identification Of Genetic Signals For “Diabesity” --- Type 2 Diabetes And Obesity -- Among African American And European American Participants In Four Cohorts Of The TOPMed Consortium

FRI660 Serum Lipids And Inflammatory Markers Reveal Race-associated Differences Between Diabetics And Non-diabetics

Serum lipidomics profiles reveal potential lipid markers for prediabetes and type 2 diabetes in patients from multiple communities

Association of LRP5, TCF7L2, and GCG Variants and Type 2 Diabetes Mellitus As Well As Fasting Plasma Glucose and Lipid Metabolism Indexes.